drugset / Trial / NCT04105114

Transformation of Paralysis to Stepping

NCT04105114

Non-randomizedCrossoverTriple-blindBasic science

Summary

The main goal of the project is to develop multiple noninvasive neuromodulatory strategies to facilitate full weight bearing stepping overground in people with paralysis. We will determine the effectiveness of combining noninvasive spinal cord stimulation and the administration of buspirone (a monoaminergic agonist) in facilitating locomotor activity in a gravity-neutral apparatus, during body weight supported stepping on a treadmill, when stepping overground, or during full weight bearing stepping overground in a rolling walker. Our objective is to identify the experimental variables that define the efficacy of these novel neuromodulatory techniques over a 5 year period in 15 participants with severe spinal cord injury who are at least one year post-injury.

Timeline

Start
2019-09-30
Primary completion
2025-08-31
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Buspirone Small molecule 7.5 mg Oral
Subject Buspirone Small molecule 10 mg Oral

Indications